DSK Co.,Ltd. · 주식등의대량보유상황보고서(일반)
Report on large shareholdings (general)
6.1
(주)디에스케이
0000
Report on Large Holdings of Shares, etc.
| (General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control) |
| To: Financial Services Commission | Reporting obligation date: | 2026-11-12 |
| To: Korea Exchange | Report reference date: | 2026-11-19 |
| Reporting person: | (주)시너지이노베이션 |
| Summary |
| Issuer name | (주)디에스케이 | Relationship to Issuer | Largest Shareholder |
| Report Type | Change |
| Number of Shares Held and Holding Ratio | | Number of Shares Held | Holding Ratio |
| Previous Report | 11,075,440 | 43.08 |
| Current Report | 11,075,440 | 43.08 |
| Shares under key agreements: number and ratio | | Number of shares, etc. | Ratio |
| Previous Report | 11,075,440 | 43.08 |
| Current Report | 11,075,440 | 43.08 |
| Number of voting rights and holding ratio | | Number of Voting Rights | Holding Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Voting rights under key agreements: number and ratio | | Number of Voting Rights | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Reason for Report | 주식매매계약 관련 잔금 미지급에 따른 계약내용 변경 |
| ※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
Part 1 Report Overview
1. Issuer information
| Company Name | (주)디에스케이 | Company code | 109740 |
| Entity type | KOSDAQ-Listed Company | Total Issued Voting Shares (shares) | 25,710,390 |
2. Major shareholder information
a. Reporting person
(1) Reporting person overview
| Report Type | Change | Joint signatories |
| Reporting person type | Domestic corporation | Nationality | Republic of Korea |
| Basis for Reporter Classification (only if reported as a statutory partnership or other entity) | - |
| Name (Entity Name) | Korean | (주)시너지이노베이션 | Chinese characters (English) | Synergy Innovation Co., Ltd. |
| Address (Head Office) [Town/District Level Only] | 경기도 성남시 중원구 사기막골로 | Date of Birth or Business Registration No., etc. | 120-81-79246 |
| Occupation (business) | 의료기기 제조업 | Relationship to Issuer | Largest Shareholder |
| Business contact and person in charge | Affiliated company | (주)시너지이노베이션 | Department | Management Support Team |
| Position | Deputy General Manager | Phone Number | 02-219** |
| Name | 김영민 | Fax number | 031-74** |
| Email address | **synergyinno.com |
(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 336,885 | Total Liabilities | 64,492 |
| Total Equity | 272,394 | Paid-in Capital | 44,053 |
| Representative (representative or managing partner) | 박진형 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | 에스이노베이션신기술조합 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 35.85 |
※ 2025년말 연결재무제표 기준입니다.
보고자의 최대주주가 법인, 기타단체, 법령상조합, 민법상 조합의 경우】- 에스이노베이션 신기술조합
| Legal form | 법령상 조합 |
| Total Assets (or Total Assets Under Management) | 74,078 | Total Liabilities | - |
| Total Equity | 74,078 | Paid-in Capital | 82,765 |
| Representative (representative or managing partner) | 시너지아이비투자(주) |
| Decision-Making Body (Decision Maker) | 조합원 총회 |
| Largest Shareholder (Largest Investor) | 시너지파트너스(주) | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 55.7 |
※ 2025년말 재무제표 기준입니다.
b. Specially related parties
(1) Specially related party overview
| No. | Name | Category | Specific Relationship to Reporter | Date of Birth or Business Registration No., etc. | Nationality | Address (Location) | Occupation (Business) | Relationship to Issuer |
| 1 | 시너지바이오조합 | 기타단체(국내) | 조합원 | 236-80-00805 | Republic of Korea | 서울특별시 서초구 강남대로 | Investment business | Shareholder |
| 2 | 김태구 | Individual (Domestic) | Officer of Affiliate | 590723 | Republic of Korea | 경기도 용인시 기흥구 석현로 | 경영자 | Executive officers (registered) |
| * Address to town/district level only |
(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)
- 시너지바이오조합
| Legal form | 민법상 조합 |
| Total Assets (or Total Assets Under Management) | 9,982 | Total Liabilities | - |
| Total Equity | 9,982 | Paid-in Capital | 22,500 |
| Representative (representative or managing partner) | 김종원 |
| Decision-Making Body (Decision Maker) | 조합원 총회 |
| Largest Shareholder (Largest Investor) | (주)시너지이노베이션 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 44.4 |
※ 2025년말 재무제표 기준입니다.
c. Collective investment manager
(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))
(1) Collective investment manager overview
| No. | Name | Business Registration No., etc. | Target collective investment vehicle | Nationality | Address (Location) | Remarks |
| - | - | - | - | - | - | - |
(2) Collective investment manager details
| Legal form | - |
| Paid-in Capital | - | Total Assets Under Management | - |
| Representative | - |
| Decision-Making Body (Decision Maker) | - |
| Largest Shareholder (Corporate Representative) | - | Largest Shareholder Stake | - |
3. Shares, etc. held and holding ratio
| Report reference date | Reporting person | Shares, etc. | Share Certificates | Total Issued Voting Shares (shares) |
| Name of Holder | Number of Specially Related Persons | Number of Shares, etc. (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) |
| Previous Report | 2026-10-08 | (주)시너지이노베이션 | 3 | 11,075,440 | 43.08 | 11,075,440 | 43.08 | 25,710,390 |
| This Report | 2026-11-19 | (주)시너지이노베이션 | 3 | 11,075,440 | 43.08 | 11,075,440 | 43.08 | 25,710,390 |
| Change | 0 | 0 | 0 | 0 | 0 |
4. Purpose of holding
| Impact on management control |
| 보고자와 특별관계자는 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각호에 대한 사항에 대하여 영향력을 행사하고 있습니다. 회사의 업무집행과 관련한 주요사항이 발생할 경우에는 관계법령 등에서 허용하는 범위 및 방법에 따라 회사의 경영목적 부합하는 의사결정을 할 예정입니다.※ 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항1. 임원의 선임ㆍ해임 또는 직무의 정지2. 이사회 등 「상법」에 따른 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4. 삭제 <2020. 1. 29.>5. 회사의 합병, 분할과 분할합병6. 주식의 포괄적 교환과 이전7. 영업전부의 양수ㆍ양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수ㆍ양도8. 자산 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익 전부를 같이하는 계약, 그 밖에 이에 준하는 계약의 체결, 변경 또는 해약10. 회사의 해산 |
5. Reason for change
| Method of change | - |
| Reason for change | - |
| Reason for Change | 주식매매계약 관련 잔금 미지급에 따른 계약내용 변경 |
Part 2 Details of Large Holdings
1. Holdings by reporting person and specially related persons
A. Holdings by type of shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Shares Held |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | (주)시너지이노베이션 | 120-81-79246 | 6,425,432 | - | - | - | - | - | - | - | - | 6,425,432 | 24.99 |
| Specially Related Party | 시너지바이오조합 | 236-80-00805 | 2,161,834 | - | - | - | - | - | - | - | - | 2,161,834 | 8.41 |
| 김태구 | 590723 | 2,488,174 | - | - | - | - | - | - | - | - | 2,488,174 | 9.68 |
| A | a1 | a2 | B | C | D | E | F | G | | |
| H |
| Total Issued Voting Shares (I) | Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H) | Holding Ratio (%) |
| Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100 | Share Holding Ratio (A / I) × 100 |
| 25,710,390 | - | 43.08 | 43.08 |
※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares
B. Holdings by form of holding
| Relationship | Name (Entity Name) | Date of Birth or Business Registration No., etc. | Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) | Total |
| No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | No. 6 | No. 7 | Number of shares | Ratio |
| Reporting person | (주)시너지이노베이션 | 120-81-79246 | 6,425,432 | - | - | - | - | - | - | 6,425,432 | 24.99 |
| Specially Related Party | 시너지바이오조합 | 236-80-00805 | 2,161,834 | - | - | - | - | - | - | 2,161,834 | 8.41 |
| 김태구 | 590723 | 2,488,174 | - | - | - | - | - | - | 2,488,174 | 9.68 |
| ※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them |
[조합원 출자 내역]
| 특별관계자(조합원) 성명 | 출자비율(%) |
| ㈜시너지이노베이션 | 44.4 |
| ㈜태광 | 19.5 |
| 강진용 | 11.1 |
| ㈜대신인터내셔날 | 4.4 |
| 윤성덕 | 4.4 |
| 심상칠 | 4.4 |
| 구정회 | 4.4 |
| ㈜대신 | 3.6 |
| 문화숙 | 2.2 |
| 최경란 | 1.3 |
| 김종원 | 0.1 |
2. Contracts on shares held
A. Contract status
| Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.) |
| Yes |
*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported
B. Contract details
| No. | Name (Entity Name) | Relationship to Reporter | Date of Birth or Business Registration No., etc. | Type of shares, etc. | Number of shares, etc. | Counterparty | Contract type | Contract date (amendment date) | Contract period | Ratio | Remarks |
| 1 | (주)시너지이노베이션 | Self | 120-81-79246 | Voting Shares | 4,768,808 | 윤진파트너스(주),제이점와이(J.Y)1호투자조합 | 주식매매계약 | 2026.11.12 | 2025.08.06~2026.11.30 | 18.55 | Note) |
| 2 | (주)시너지이노베이션 | Self | 120-81-79246 | Voting Shares | 828,312 | (주)지브로파트너스 | 주식매매계약 | 2026.11.12 | 2025.08.06~2026.11.30 | 3.22 | Note) |
| 3 | (주)시너지이노베이션 | Self | 120-81-79246 | Voting Shares | 828,312 | (주)더블유에이치파트너스 | 주식매매계약 | 2026.11.12 | 2025.08.06~2026.11.30 | 3.22 | Note) |
| 4 | 시너지바이오조합 | Related party | 236-80-00805 | Voting Shares | 2,161,834 | 윤진파트너스(주),제이점와이(J.Y)1호투자조합 | 주식매매계약 | 2026.11.12 | 2025.08.06~2026.11.30 | 8.41 | Note) |
| 5 | 김태구 | Related party | 590723 | Voting Shares | 1,244,087 | 원마인드1호조합 | 주식매매계약 | 2026.11.12 | 2025.08.06~2026.11.30 | 4.84 | Note) |
| 6 | 김태구 | Related party | 590723 | Voting Shares | 1,244,087 | 씨앤케이6조합 | 주식매매계약 | 2026.11.12 | 2025.08.06~2026.11.30 | 4.84 | Note) |
| Total (number of shares, etc.) | 11,075,440 | Total (ratio) | 43.08 | Note) |
주1) (주)시너지이노베이션, 시너지바이오조합, 김태구는 상기와 같은 내용으로 윤진파트너스(주)외 5인과 발행회사에 대한 주식매매계약을 체결하였습니다.주2) 주식 및 경영권양수도계약 주요일정- 계약체결일: 2025.08.06- 1차 변경계약체결일: 2025.09.25- 2차 변경계약체결일: 2025.11.13- 3차 변경계약체결일: 2026.03.31- 4차 잔금일 연기 합의일(공문 통지 및 확인서 회신): 2026.06.15- 5차 변경계약체결일: 2026.06.29- 6차 변경계약체결일: 2026.07.28- 7차 변경계약체결일: 2026.08.04- 8차 변경계약체결일: 2026.09.30- 변경잔금지급일: 2026.11.12 (매수인 잔금 미지급)- 최종 거래종결기한: 2026.11.30주3) 잔금은 거래종결의 선행조건(*)이 모두 충족되는 것을 전제로, 매도인이 발행회사의 주식을 이전하고 매수인이 잔금을 지급하는 거래종결 시점에 지급되는 금액을 의미합니다. 매도인은 잔금 전액 수령 즉시 대상주식의 소유권을 매수인 명의 증권계좌로 이전하고, 본 계약 및 관련 합의서상 의무를 이행할 예정입니다.[(*) '프로톡스'에서 식약처에 기 제출한 보툴리눔 톡신 품목허가 관련 조건 및 디에스케이 임시주주총회 소집 개최 등 거래종결을 위한 절차 및 조건이 모두 충족되는 경우]당사는 2026-09-30 체결한 추가계약에 따라 잔금 지급기한을 2026-11-12로 변경하였으나, 동 기한까지 매수인 측이 잔금을 지급하지 아니하여 매수인의 귀책사유에 따른 계약해제 사유가 발생하였습니다.본 거래의 최종 거래종결기한은 2026-11-30이며, 향후 계약해제 여부 등 본 거래와 관련한 주요 사항이 결정되거나 변동사항이 발생하는 경우 관련 법령 및 규정에 따라 지체 없이 공시할 예정입니다. 상기 계약 관련 세부사항은 당사가 2026-11-12 제출한 주요사항보고서(타법인 주식 및 출자증권 양도결정) 정정공시 내용을 참조하시기 바랍니다.
C. Additional details if the main contract is a security agreement
| No. | Number of shares, etc. | Loan amount | Debtor | Interest rate | Collateral maintenance ratio | Other |
| - | - | - | - | - | - | - |
3. Holdings by proprietary and customer account (financial institutions only)
| Name | Relationship to Reporter | By account | Total |
| Own Account (shares) | Ratio (%) | Customer account (shares) | Ratio (%) | Total (shares) | Ratio (%) |
| - | - | - | - | - | - | - | - |
| Total | - | - | - | - | - | - |
Part 3 Material Changes Since Last Report Date
1. Summary of changes
a. Changes in shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Changes in Shares, etc. |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | (주)시너지이노베이션 | 120-81-79246 | - | - | - | - | - | - | - | - | - | - | - |
| Specially Related Party | 시너지바이오조합 | 236-80-00805 | - | - | - | - | - | - | - | - | - | - | - |
| 김태구 | 590723 | - | - | - | - | - | - | - | - | - | - | - |
2. Change details
a. Detailed changes in shares, etc.
| Name (Entity Name) | Date of Birth or Business Registration No., etc. | Change Date* | Acquisition/disposal method | Type of shares, etc. | Change details | Acquisition/disposal unit price** | Remarks |
| Before Change | Change | After Change |
| - | - | - | - | - | - | - | - | - | - | - |
* For trades on the securities market, the contract date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities
3. Source of acquisition funds
(1) Overview of acquisition funds
| Name | Date of birth or business registration no., etc. | Own funds (H) | Borrowings (I) | Other (J) | Total (H+I+J) |
| - | - | - | - | - | - |
(2) Origin and source of acquisition funds